DE60203929D1 - Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung - Google Patents

Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung

Info

Publication number
DE60203929D1
DE60203929D1 DE60203929T DE60203929T DE60203929D1 DE 60203929 D1 DE60203929 D1 DE 60203929D1 DE 60203929 T DE60203929 T DE 60203929T DE 60203929 T DE60203929 T DE 60203929T DE 60203929 D1 DE60203929 D1 DE 60203929D1
Authority
DE
Germany
Prior art keywords
prevention
pharmaceutical composition
treatment procedure
emergency
consumer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60203929T
Other languages
English (en)
Other versions
DE60203929T2 (de
Inventor
Look F Van
Illesne Balogh
Katalin Komandi
Laszlo Nemes
Zsolt Szabo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Application granted granted Critical
Publication of DE60203929D1 publication Critical patent/DE60203929D1/de
Publication of DE60203929T2 publication Critical patent/DE60203929T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE60203929T 2001-11-27 2002-11-26 Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung Expired - Lifetime DE60203929T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0105173 2001-11-27
HU0105173A HU227198B1 (en) 2001-11-27 2001-11-27 Pharmaceutical composition for emergency contraception containing levonorgestrel
PCT/HU2002/000129 WO2003045397A1 (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception

Publications (2)

Publication Number Publication Date
DE60203929D1 true DE60203929D1 (de) 2005-06-02
DE60203929T2 DE60203929T2 (de) 2006-01-19

Family

ID=89998939

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60203929T Expired - Lifetime DE60203929T2 (de) 2001-11-27 2002-11-26 Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung

Country Status (33)

Country Link
US (1) US20050288264A2 (de)
EP (1) EP1448207B1 (de)
JP (1) JP2005516904A (de)
KR (1) KR100908161B1 (de)
CN (1) CN1551774A (de)
AP (1) AP1849A (de)
AT (1) ATE293978T1 (de)
AU (1) AU2002347401A1 (de)
BR (1) BR0210595A (de)
CA (1) CA2450359C (de)
DE (1) DE60203929T2 (de)
DK (1) DK1448207T3 (de)
EA (1) EA006545B1 (de)
EC (1) ECSP045171A (de)
ES (1) ES2239727T3 (de)
GE (1) GEP20063882B (de)
HR (1) HRP20040584B1 (de)
HU (1) HU227198B1 (de)
IL (1) IL159394A0 (de)
IS (1) IS2691B (de)
MA (1) MA27076A1 (de)
MX (1) MXPA04005104A (de)
NO (1) NO333984B1 (de)
NZ (1) NZ530056A (de)
OA (1) OA12730A (de)
PL (1) PL206010B1 (de)
PT (1) PT1448207E (de)
RS (1) RS50768B (de)
SI (1) SI1448207T1 (de)
TN (1) TNSN04048A1 (de)
UA (1) UA79942C2 (de)
WO (1) WO2003045397A1 (de)
ZA (1) ZA200404114B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7867515B2 (en) * 2006-12-20 2011-01-11 TEVA Woman's Health, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
AU2008341138A1 (en) * 2007-12-20 2009-07-02 Teva Women's Health, Inc. Dosage regimens and pharmaceutical compositions and packages for emergency contraception
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
US9180131B2 (en) 2008-12-12 2015-11-10 Laboratoire Hra Pharma Method for contraception
EP2419108B1 (de) 2009-04-14 2016-08-17 Laboratoire HRA Pharma Verfahren zur bedarfsweisen kontrazeption
MY158476A (en) 2009-06-23 2016-10-14 Bayer Ip Gmbh Pharmaceutical composition for emergency contraception
CN101732324B (zh) * 2009-12-31 2011-12-07 广州朗圣药业有限公司 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
HUE029252T2 (en) 2011-06-01 2017-02-28 Estetra Sprl Process for the preparation of intermediates of estetrol
DK2714712T3 (en) 2011-06-01 2016-12-05 Estetra Sprl A process for the preparation of intermediates estetrol
EP2383279A1 (de) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Herstellungsverfahren für Esterol
US9579329B2 (en) * 2011-08-11 2017-02-28 Estetra S.P.R.L. Use of estetrol as emergency contraceptive
CN104797258A (zh) 2012-11-22 2015-07-22 拜耳药业股份公司 包含左炔诺孕酮和cox抑制剂的药物组合物用于按需避孕的用途和施用方法
JP6370887B2 (ja) 2013-05-23 2018-08-08 バイエル・ファルマ・アクティエンゲゼルシャフト オンデマンド避妊のための医薬組成物およびその使用、ならびにこの医薬組成物の適用体制
CN103877058A (zh) * 2014-03-26 2014-06-25 邵娜 一种左炔诺孕酮片及其制备工艺
RS61812B1 (sr) 2015-06-18 2021-06-30 Estetra Sprl Oralno-disperzibilna tableta koja sadrži estetriol
AU2016280863B2 (en) 2015-06-18 2021-04-01 Estetra Srl Orodispersible dosage unit containing an estetrol component
KR102662025B1 (ko) 2015-06-18 2024-05-02 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 에스테트롤 성분을 함유하는 구강분해성 투여 단위
MD3310346T2 (ro) 2015-06-18 2021-06-30 Estetra Sprl Comprimată orodispersabilă ce conține estetrol
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
CN110917154A (zh) * 2019-12-12 2020-03-27 上海信谊天平药业有限公司 一种左炔诺孕酮片的制备方法
US20230338355A1 (en) * 2020-07-30 2023-10-26 Acer Therapeutics Inc. Nk antagonists for contraception

Also Published As

Publication number Publication date
HUP0105173D0 (en) 2002-02-28
DE60203929T2 (de) 2006-01-19
HUP0105173A3 (en) 2004-03-29
MA27076A1 (fr) 2004-12-20
PL206010B1 (pl) 2010-06-30
PT1448207E (pt) 2005-08-31
UA79942C2 (en) 2007-08-10
IL159394A0 (en) 2004-06-01
KR20040066088A (ko) 2004-07-23
RS50768B (sr) 2010-08-31
EP1448207B1 (de) 2005-04-27
KR100908161B1 (ko) 2009-07-16
SI1448207T1 (en) 2005-10-31
PL369520A1 (en) 2005-04-18
IS7065A (is) 2003-12-05
WO2003045397A1 (en) 2003-06-05
CA2450359A1 (en) 2003-06-05
NO333984B1 (no) 2013-11-04
BR0210595A (pt) 2004-06-08
TNSN04048A1 (en) 2006-06-01
EP1448207A1 (de) 2004-08-25
IS2691B (is) 2010-10-15
ATE293978T1 (de) 2005-05-15
MXPA04005104A (es) 2004-08-19
ES2239727T3 (es) 2005-10-01
HRP20040584A2 (en) 2005-02-28
JP2005516904A (ja) 2005-06-09
NZ530056A (en) 2005-02-25
RS4204A (en) 2007-02-05
CN1551774A (zh) 2004-12-01
NO20041607L (no) 2004-04-20
ZA200404114B (en) 2005-10-26
DK1448207T3 (da) 2005-06-27
AP2004003046A0 (en) 2004-06-30
HU227198B1 (en) 2010-10-28
US20050288264A2 (en) 2005-12-29
ECSP045171A (es) 2004-08-27
AU2002347401A1 (en) 2003-06-10
HUP0105173A2 (hu) 2003-08-28
AP1849A (en) 2008-05-23
EA006545B1 (ru) 2006-02-24
GEP20063882B (en) 2006-07-25
OA12730A (fr) 2006-06-28
HRP20040584B1 (en) 2012-11-30
CA2450359C (en) 2011-05-10
US20050032755A1 (en) 2005-02-10
EA200400731A1 (ru) 2004-12-30

Similar Documents

Publication Publication Date Title
DE60203929D1 (de) Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung
EP1399171A4 (de) Medizinische kräuterverbindungen zur prävention und behandlung von diabetes
DE60121992D1 (de) Zusammensetzung zur verabreichung und beschichtung medizinischer geräte
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
DE60232251D1 (de) Pharmazeutische zusammensetzungen zur behandlung von asthma
HU0103558D0 (en) Pharmaceutical composition for the treatment of stroke and traumatic brain insury
HK1092061A1 (en) Periodontal disease therapeutic and/or preventive composition
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
BRPI0209720A2 (pt) dosagem e embalagem de medicação com liberação controlada
EP1604664A4 (de) Medikament zur vorbeugung und behandlung von arteriosklerose und bluthochdruck
AU2003202075A1 (en) Modulator of the notch signalling pathway and use thereof in medical treatment
AU2002248319A1 (en) Pharmaceutical composition for the prevention and treatment of scar tissue
HUP0400119A3 (en) Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite
AU2002345255A1 (en) Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
PL362920A1 (en) Therapeutic film forming composition and treatment system
AU2003226537A8 (en) Modulators of the notch signalling pathway and uses thereof in medical treatment
GB0108470D0 (en) Pharmaceutical compositions and their use
HK1062810A1 (en) Use of il-18 inhibitors for the manufacture of medicaments for treatment and/or prevention of heartdisease
HK1064042A1 (en) Medicines and medicinal kits
HUP0401913A3 (en) Medicine for preventing and treating bromhidrosis
AU2002349268A1 (en) Medicine for preventing and treating bromidrosis
AU2002325169A1 (en) Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
DE60107900D1 (de) Pharmazeutische Zusammensetzung und Nahrungsmittel zur Behandlung von Gehirnödem
HUP0103017A3 (en) Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
EE200200698A (et) Ravimid neurodegeneratiivsete haiguste ennetamiseks ja raviks

Legal Events

Date Code Title Description
8364 No opposition during term of opposition